Leaflet BEVACOMB 10mg / 160mg film-coated tablets

Product code:
W63568005
Quantity:
56
Indicated for:
hypertension
Route of administration:
oral
Substance:
amlodipine + valsartan (calcium channel blocker + angiotensin II receptor blocker)
ATC
C09DB01 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Precautions:

Contraindicated during pregnancy

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances

Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of amlodipine and valsartan is used to treat essential hypertension (high blood pressure) in patients who cannot control their blood pressure with a single medication. This combination helps reduce the risk of cardiovascular complications, such as heart attack or stroke.

Amlodipine is a calcium channel blocker that relaxes blood vessels, improving blood flow and lowering blood pressure. Valsartan is an angiotensin II receptor blocker (ARB) that blocks the effects of angiotensin II, a hormone that causes blood vessel constriction, thereby helping to lower blood pressure.

This combination is effective in reducing blood pressure through complementary mechanisms: amlodipine acts on the smooth muscles of blood vessels, while valsartan prevents hormonal effects that lead to vessel constriction. It is particularly indicated for patients requiring combination therapy for optimal blood pressure control.

Common side effects include dizziness, headache, swelling (especially in the ankles), fatigue, nausea, or palpitations. In rare cases, allergic reactions, severe hypotension, or kidney impairment may occur. Regular medical monitoring is essential to adjust the treatment if necessary.

Patients should strictly follow their doctor’s instructions regarding dosage and avoid excessive salt or alcohol consumption. It is also recommended to inform the doctor about other medications being taken or pre-existing conditions, such as kidney or liver impairment.

General data about BEVACOMB 10mg / 160mg

Substance:
amlodipine + valsartan
Date of latest medicines list:
01-06-2026
Product code:
W63568005
Concentration:
10mg / 160mg
Pharmaceutical form:
film-coated tablets
Quantity:
56
Product type:
Generic medicine
Price:
135.69 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
BALKANPHARMA-DUPNITZA AD - BULGARIA
Holder:
ACTAVIS GROUP PTC EHF. - ISLANDA
Number:
13943/2021/01
Shelf life:
3 years

Concentrations available for amlodipine + valsartan

  • 10mg/160mg
  • 10mg/320mg
  • 5mg/160mg
  • 5mg/320mg
  • 5mg/80mg

Combinations with other substances